Search For "limus drug eluting stent"
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTI
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 15: MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel siroli
Read More
Over 1,000 patients enrolled in Landmark SELUTION DeNovo Study
Updated : 3 years ago IST
Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment st
Read More
First patient enrolled in SELUTION SLR IDE BTK Study
Updated : 3 years, 9 months ago IST
Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval.
Read More
MedAlliance announces first patient enrolled in the 3,300 Patient Landmark
Updated : 4 years, 6 months ago IST
Geneva [Switzerland], September 1 (ANI/PRNewswire): MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], ver
Read More